Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Compass 3: A Novel Transition Program to Reduce Disability After Stroke [NA]

View source ↗

Summary

Compass 3 is a clinical trial evaluating a transition program to reduce disability after stroke, with recruitment ongoing at Washington University School of Med…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Washington University School of Medicine | Conditions: Stroke | NA | Status: RECRUITING